4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-20-026302
Chief Financial Officer sold 1,741 shares at $102.49 ($178,435)
From the SEC's structured data for this filing
Trades in this filing
ABERNETHY MATT · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-04-28 | Sale : show line 1 in the form | −1,741 | $102.49 | $178,435 | 5,953 | D |
| Open-market sales · 1,741 sh · avg $102.49 · $178,435 | ||||||
Loading xslF345X03/doc4.xml…